Intra Cellular Therapies (United States)
- Research works
- 69 ▲ 156% vs 2013–17
- Citations
- 2k 29.1 per fractional work
- Top-10% rate
- 8.1% record average 16.5%
- Open access
- 57% world 28%
Not ranked overall: Intra Cellular Therapies (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 19.6×. Every wedge is a field page.
- Neuroscience 19.6×
- Chemistry 2.4×
- Medicine 2.4×
- Biochemistry, Genetics and Molecular Biology 2.0×
- Mathematics 1.6×
- Decision Sciences 0.9×
- Psychology 0.6×
- Immunology and Microbiology 0.2×
- Health Professions 0.2×
- Arts and Humanities 0.1×
- Social Sciences 0.1×
- Computer Science 0.1×
- Engineering 0.1×
- Materials Science 0.0×
Who are the top researchers at Intra Cellular Therapies (United States)?
Ranked on the composite score, Robert E. Davis and Suresh Durgam lead among researchers whose main affiliation is Intra Cellular Therapies (United States).
- 1 Robert E. Davis United States · #197,670 worldwide 88 citations · 26 works
- 2 Suresh Durgam United States · #671,936 worldwide 70 citations · 29 works
Which keywords describe research at Intra Cellular Therapies (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Depression, Oxidative Stress, Neuroinflammation, Cytokines, Microglia, Schizophrenia, Immune Activation and Tryptophan Metabolism.
- Neurocognitive Deficits
- Neuroprotection
- Cholinesterase Inhibitors
- Acetylcholinesterase
- Cell Signaling
- Neurological Disorders
- Ketamine
- Cognitive Impairment
- Clinical Guidelines
- Treatment Guidelines
- Neurodegenerative Diseases
- cAMP Signaling
- Pharmacology
- Synaptic Plasticity
- Therapeutic Targets
- Neurobiology
- Tryptophan Metabolism
- Schizophrenia
- Cytokines
- Oxidative Stress
- Depression
- Neuroinflammation
- Microglia
- Immune Activation
- Inflammation
- Genetics
- Prevalence
- Cognitive Function
- Cyclic Nucleotide Phosphodiesterases
- Bipolar Spectrum Disorder
- Neuroimaging
- Alzheimer's Disease
- Stress
- Antidepressant
- Metabolic Syndrome
- Drug Discovery
- Drug Development
- Cancer Therapy
- Crystal Structure
- Antipsychotic Drugs
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Depression14▲ 27×8 topics
- Oxidative Stress11▲ 8.6×13 topics
- Neuroinflammation10▲ 52×4 topics
- Cytokines9▲ 49×3 topics
- Microglia9▲ 148×2 topics
- Schizophrenia8▲ 94×3 topics
- Immune Activation8▲ 126×1 topic
- Tryptophan Metabolism8▲ 291×1 topic
- Inflammation8▲ 4.8×15 topics
- Neurobiology7▲ 31×6 topics
- Genetics6▲ 12×6 topics
- Therapeutic Targets6▲ 36×2 topics
- Prevalence6▲ 21×3 topics
- Synaptic Plasticity6▲ 27×3 topics
- Cognitive Function5▲ 35×3 topics
- Pharmacology5▲ 21×2 topics
- Cyclic Nucleotide Phosphodiesterases4▲ 697×1 topic
- cAMP Signaling4▲ 697×1 topic
- Bipolar Spectrum Disorder4▲ 219×1 topic
- Neurodegenerative Diseases4▲ 27×3 topics
- Neuroimaging4▲ 21×1 topic
- Treatment Guidelines4▲ 28×2 topics
- Alzheimer's Disease4▲ 21×4 topics
- Clinical Guidelines4▲ 18×2 topics
- Stress4▲ 14×3 topics
- Cognitive Impairment4▲ 23×2 topics
- Antidepressant4▲ 190×1 topic
- Ketamine4▲ 190×1 topic
- Metabolic Syndrome3▲ 5.3×4 topics
- Neurological Disorders3▲ 6.7×6 topics
- Drug Discovery3▲ 11×4 topics
- Cell Signaling3▲ 12×3 topics
- Drug Development3▲ 28×2 topics
- Acetylcholinesterase3▲ 133×1 topic
- Cancer Therapy3▲ 6.1×8 topics
- Cholinesterase Inhibitors3▲ 133×1 topic
- Crystal Structure3▲ 15×2 topics
- Neuroprotection3▲ 10×3 topics
- Antipsychotic Drugs2▲ 65×1 topic
- Neurocognitive Deficits2▲ 65×1 topic
Which research topics does Intra Cellular Therapies (United States) publish most on?
By volume in 2022–2025: Bipolar Disorder and Treatment, Tryptophan and brain disorders, Treatment of Major Depression and Attention Deficit Hyperactivity Disorder.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Bipolar Disorder and Treatment Psychiatry and Mental health 3 works
- 2 Tryptophan and brain disorders Biological Psychiatry 3 works
- 3 Treatment of Major Depression Pharmacology 1 works
- 4 Attention Deficit Hyperactivity Disorder Psychiatry and Mental health 1 works
- 5 Stress Responses and Cortisol Behavioral Neuroscience 1 works
- 6 Phosphodiesterase function and regulation Molecular Biology 1 works
- 7 Synthesis and Catalytic Reactions Organic Chemistry 1 works
- 8 Circadian rhythm and melatonin Endocrine and Autonomic Systems 0 works
- 9 Schizophrenia research and treatment Psychiatry and Mental health 0 works
- 10 Pharmacological Receptor Mechanisms and Effects Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Intra Cellular Therapies (United States)'s research output changed?
Output in 2018–2022 was 156% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in New York
- Columbia University
- New York University
- Icahn School of Medicine at Mount Sinai
- Memorial Sloan Kettering Cancer Center
- City University of New York
- Human Growth Foundation
- Columbia University Irving Medical Center
- Rockefeller University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.